Darwin Alpha Joins GXG Markets as Adviser

robertbearclaw.com
New York, New York--(Newsfile Corp. - December 2, 2020) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Mesoblast Limited (Mesoblast or the Company) (NASDAQ: MESO) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Mesoblast securities between April 16, 2019 and October 1, 2020, both dates inclusive (the Class Period). Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/meso . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements that: (1) comparative analyses between Mesoblasts Phase 3 trial and three historical studies did not support the effectiveness of remestemcel-L for steroid refractory acute graft versus host disease (aGVHD) due to design differences between the four studies; (2) as a result, the United States Food and Drug Administration was reasonably likely to require further clinical studies; (3) as a result, the commercialization of remestemcel-L in the U.S. was likely to be delayed; and (4) as a result of the foregoing, defendants positive statements about the Companys business, operations, and prospects were materially misleading and/or lacked a reasonable basis. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firms site: www.bgandg.com/meso or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Mesoblast you have until December 7, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesnt require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firms expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes. Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz Story continues 212-697-6484 | info@bgandg.com To view the source version of this press release, please visit https://www.newsfilecorp.com/release/68966 View comments
Unlocking Wisdom: 6 Essential Investment Insights from Warren Buffett
Explore 6 vital investment insights from Warren Buffett's annual letters that guide investors toward financial success.